Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trait vs. State Markers for Schizophrenia: Identification and Characterization through Visual Processes.

Yue Chen1, L Cinnamon Bidwell, Daniel Norton

  • 1Department of Psychiatry, Harvard Medical School, USA.

Current Psychiatry Reviews
|May 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cannabidiol at the crossroads: panacea, placebo, or problem?

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Physical Activity Level Moderates Cannabis-Associated Reductions in Negative Affect in Anxious Individuals.

Clinical therapeutics·2026
Same author

The highs and lows: Cannabis use and positive valence bipolar mood and emotion processes in emerging adults.

Journal of affective disorders·2026
Same author

Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products.

International journal of environmental research and public health·2026
Same author

Age differences in endocannabinoid tone are ameliorated after recent cannabis use.

Scientific reports·2026
Same author

Naturalistic investigation of cannabis strains varying in THC and CBD ratios and verbal recognition memory.

Frontiers in psychology·2026

Schizophrenia research identifies visual function differences. Motion discrimination deficits appear in patients and relatives, suggesting trait markers, while motion integration issues are specific to patients, indicating state markers.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Visual Science

Background:

  • Identifying reliable markers for schizophrenia is crucial for early detection and intervention.
  • Distinguishing between trait (enduring) and state (transient) markers is key to understanding schizophrenia's underlying mechanisms.
  • Visual functions are increasingly recognized for their potential as biological markers in psychiatric disorders.

Purpose of the Study:

  • To investigate visual processing differences in schizophrenia patients, their unaffected relatives, and bipolar disorder patients.
  • To determine which visual functions may serve as trait or state markers for schizophrenia.
  • To inform the development of targeted intervention strategies for schizophrenia.

Main Methods:

  • Comparative analysis of visual functions (motion integration and discrimination) across three groups: schizophrenia patients, clinically unaffected relatives, and bipolar disorder patients.

Related Experiment Videos

  • Assessment of visual response traits to differentiate between enduring and transient markers.
  • Synthesis of existing research on visual processing in schizophrenia.
  • Main Results:

    • Schizophrenia patients exhibited deficits in both motion integration and motion discrimination.
    • Unaffected relatives of schizophrenia patients showed deficits in motion discrimination but not motion integration.
    • Bipolar disorder patients did not show significant deficits in either motion integration or discrimination.

    Conclusions:

    • Motion discrimination appears to be a potential trait marker for schizophrenia, present in patients and their relatives.
    • Motion integration deficits seem to be state markers, specific to active schizophrenia.
    • Differentiating visual trait and state markers aids in developing more effective, neurobiologically informed interventions for schizophrenia.